KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: Özel Sayı 1

Post-COVID syndrome: pulmonary complications

Aydın YILMAZ
Tevfik ÖZLÜ
Dorina ESENDAĞLI
Şule AKÇAY
Sayfa
3359–3371
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This review summarizes the current literature regarding the pulmonary complications in post-COVID syndrome and the management of these conditions.Key words: Post-COVID, pulmonary complications, multisystem inflammatory syndrome in adults (MIS-A)

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worlwide and caused a pandemic that is still ongoing.
📊
Temel Bulgular & Veri:The virus can cause a disease named as COVID-19, which is composed of multi systemic manifestations with a pulmonary system predominance.
💡
Sonuç & Katkı:This review summarizes the current literature regarding the pulmonary complications in post-COVID syndrome and the management of these conditions.Key words: Post-COVID, pulmonary complications, multisystem inflammatory syndrome in adults (MIS-A)
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease named as COVID-19, which is composed of multi systemic manifestations with a pulmonary system predominance. As the time passes, we are dealing more and more with a wide variety of effects and complications of the disease in survivors as far as with concerns about the clinical outcome and the timeline of symptoms in different patients. Since the lungs are the most involved organs and the post-COVID prolonged and persistent effects are mainly related to the pulmonary system, it is crucial to define and predict the outcome and to determine the individuals that can progress to fibrosis and loss of function of lungs. This review summarizes the current literature regarding the pulmonary complications in post-COVID syndrome and the management of these conditions.Key words: Post-COVID, pulmonary complications, multisystem inflammatory syndrome in adults (MIS-A)

🔖

Bu Makaleye Atıf Yap

YILMAZ, A., ÖZLÜ, T., ESENDAĞLI, D., AKÇAY, Ş. (2022). Post-COVID syndrome: pulmonary complications. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: Özel Sayı 1, 3359–3371. https://ajindex.com/articles/609322

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. The Journal of Heart and Lung Transplantation 2020
  2. 39(5): 405-407. doi: 10.1016/j.healun.2020.03.012 2. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020
  3. 395(10223): 497-506. doi: 10.1016/S0140- 6736(20)30183-5 3. Zhou F, Yu T, Du R, Fan G, Liu Y et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020
  4. 395(10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3 4. Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. The European Respiratory Journal 2020
  5. 55(5): 2001009. doi: 10.1183/13993003.01009-2020 5. Sokolowska M, Lukasik ZM, Agache I, Akdis CA, Akdis D et al. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 2020
  6. 75(10): 2445-2476. doi: 10.1111/all.14462 6. Zeng QL, Li GM, Ji F, Ma SH, Zhang GF et al. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective study. Transboundary and Emerging Diseases 2020
  7. 67(6): 2971-2982. doi: 10.1111/ tbed.13674 7. Shah W, Hillman T, Playford E D, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021
  8. n136 doi:10.1136/bmj. n136 8. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clinical Reviews in Allergy and Immunology 2021
  9. 1–9. doi: 10.1007/s12016-021-08848-3 9. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. Morbidity and Mortality Weekly Report 2020
  10. 69(30): 993-998. doi: 10.15585/mmwr.mm6930e1 10. Cirulli E, Barrett KM, Riffle S, Bolze A, Neveux I et al. Longterm COVID-19 symptoms in a large unselected population. Medrxiv. 2020 Jan 1. 11. Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 PostAcute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020
  11. 324(6): 603-605. doi: 10.1001/ jama.2020.12603 12. Bowles KH, McDonald M, B